Cardiovascular Pharmacology and Drug Therapy

Promoting research, teaching and clinical activities

ESC Working Group Cardiovascular Pharmacology and Drug Therapy Chair Ruilope

The ESC Working Group on Cardiovascular Pharmacology and Drug Therapy aims to promote research, teaching and clinical activity, as well as advising the ESC Board on matters relating to Cardiovascular Pharmacology and Drug Therapy.

One particular focus of our Working Group is "trials science", i.e., the discipline dealing with the planning, conduct and evaluation of evidence gained through cardiovascular trials.

The Working Group contributes actively to the organisation of the ESC Congress and the generation of the ESC Guidelines.The dedicated congress of the Working Group (as co-organiser) is the "Global-CVCT" (Cardiovascular Clinical Trialists Forum"), which takes place in Cannes every December. It aims at bringing together Cardiologists, Academia, Industry and Regulatory Authorities for in-depth discussion of trials science.

Prof. Luis Miguel RUILOPE, FESC
Chairman 2010-2012

QUICK ACCESS

8th CVCT 1-3 December 2011 Paris, France Report on CVCT 2010	Apply now and get automatic membership to ESC	Latest FCP scientific articles authored by the Working Group

Anaemia in heart failure: intravenous iron therapy

Intravenous iron has emerged as a well tolerated and effective therapy to improve symptoms and quality of life in both anaemic and non-anaemic heart failure patients with iron deficiency...(An article from the E-Journal of the ESC Council for Cardiology Practice)